These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3296682)

  • 1. The role of the LDL receptor in lipoprotein metabolism.
    Bilheimer DW; Grundy SM
    Adv Exp Med Biol; 1987; 210():123-30. PubMed ID: 3296682
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of low-density lipoprotein apolipoprotein B levels.
    Kesäniemi YA; Färkkilä M; Kervinen K; Koivisto P; Vuoristo M; Miettinen TA
    Am Heart J; 1987 Feb; 113(2 Pt 2):508-13. PubMed ID: 3812209
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence of non-deficient low-density lipoprotein receptor patients in a pool of subjects with clinical familial hypercholesterolemia profile.
    Lestavel-Delattre S; Benhamamouch S; Agnani G; Luc G; Bard JM; Brousseau T; Billardon C; Kusnierz JP; De Gennes JL; Fruchart JC
    Metabolism; 1994 Apr; 43(4):397-402. PubMed ID: 8159093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
    März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
    J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular aspects of human lipid metabolism.
    Angelin B; Rudling M
    Eur J Clin Nutr; 1992 Mar; 46(3):153-60. PubMed ID: 1559520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of apolipoprotein E in modulating the metabolism of apolipoprotein B-48 and apolipoprotein B-100 containing lipoproteins in humans.
    Gregg RE; Brewer HB
    Adv Exp Med Biol; 1986; 201():289-98. PubMed ID: 3541520
    [No Abstract]   [Full Text] [Related]  

  • 7. Monogenic disorders that cause LDL cholesterol to accumulate in plasma.
    Desjeux JF
    J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):119-21. PubMed ID: 11568509
    [No Abstract]   [Full Text] [Related]  

  • 8. Causes of high blood cholesterol.
    Grundy SM; Vega GL
    Circulation; 1990 Feb; 81(2):412-27. PubMed ID: 2404630
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.
    Schmidt HH; Stuhrmann M; Shamburek R; Schewe CK; Ebhardt M; Zech LA; Büttner C; Wendt M; Beisiegel U; Brewer HB; Manns MP
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2167-74. PubMed ID: 9626156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family study in familial hypercholesterolemia with a receptor-negative homozygous 9-year-old boy.
    Clemens P; Beisiegel U; Steinhagen-Thiessen E
    Helv Paediatr Acta; 1986 Aug; 41(3):173-82. PubMed ID: 2944857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia.
    Bilheimer DW; Goldstein JL; Grundy SM; Starzl TE; Brown MS
    N Engl J Med; 1984 Dec; 311(26):1658-64. PubMed ID: 6390206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monocyte colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and -independent pathways in rabbits.
    Shimano H; Yamada N; Ishibashi S; Harada K; Matsumoto A; Mori N; Inaba T; Motoyoshi K; Itakura H; Takaku F
    J Biol Chem; 1990 Aug; 265(22):12869-75. PubMed ID: 2198280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern management of hyperlipidemia.
    Grundy SM
    Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992
    [No Abstract]   [Full Text] [Related]  

  • 14. Meaning of a modified LDL in humans.
    Avogaro P; Bittolo Bon G; Cazzolato G
    Adv Exp Med Biol; 1987; 210():209-12. PubMed ID: 3591550
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia.
    Valdivielso P; Escolar JL; Cuervas-Mons V; Pulpón LA; Chaparro MA; González-Santos P
    Ann Intern Med; 1988 Feb; 108(2):204-6. PubMed ID: 3277507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for gene therapy of familial hypercholesterolemia.
    Wilson JM; Chowdhury JR
    Mol Biol Med; 1990 Jun; 7(3):223-32. PubMed ID: 2215209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective apheresis of low-density lipoproteins].
    Griskevicius A; Audzijoniene J
    Medicina (Kaunas); 2006; 42(6):499-503. PubMed ID: 16816545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective apheresis of low-density lipoproteins in a child].
    Griskevicius A; Audzijoniene J; Petrulioniene Z; Laucevicius A
    Medicina (Kaunas); 2007; 43(11):879-82. PubMed ID: 18084145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans.
    Hoeg JM; Demosky SJ; Gregg RE; Schaefer EJ; Brewer HB
    Science; 1985 Feb; 227(4688):759-61. PubMed ID: 2982214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
    Demant T; Bedford D; Packard CJ; Shepherd J
    J Clin Invest; 1991 Nov; 88(5):1490-501. PubMed ID: 1939641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.